FDA tobacco oversight bill passes to President
This article was originally published in The Rose Sheet
Executive SummaryBipartisan legislation giving FDA regulatory responsibility over production, sale and marketing of tobacco products passes House June 12 after clearing Senate the day before. The Family Smoking Prevention and Tobacco Control Act moves next to the White House for signature promised by President Obama. H.R. 1256 requires agency to establish a Center for Tobacco Products within 90 days upon enactment of the law. Counting FDA's Center for Toxicological Research, tobacco brings total number of FDA centers to seven. User fees will fund program; legislators behind the bill maintain resources will not be diverted from other activities
You may also be interested in...
Updated data from a postmarket study of Abiomed’s Impella RP right-heart pump further supports the device’s safety for a specific patient population.
The new US-Mexico-Canada (USMCA) trade agreement includes language on enhancing regulatory compatibility between the three countries by recognizing quality systems audits performed under the Medical Device Single Audit Program (MDSAP). It also stipulates that each trading partner “consider its resources and technical capacity” in ensuring the safety, effectiveness and quality of devices – and more. Medtech industry advocacy group AdvaMed is praising the deal, reached by the three countries on 10 December.
Novo Nordisk’s CEO talks to Scrip about the promise of glucose-responsive insulin, stem cell therapy, and a diabetes landscape without Sanofi.